141 related articles for article (PubMed ID: 28260147)
1. Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.
Hirabayashi T; Takahashi H; Watanabe M; Tachibana T
Hum Cell; 2017 Oct; 30(4):319-326. PubMed ID: 28260147
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of human lingual squamous cell carcinoma cell lines designated Nialym derived from metastatic foci of lymph node, and Nialymx derived from transplanted tumor of Nialym cells.
Takahashi H; Ishikawa H; Mataga I; Tanaka A
Hum Cell; 2015 Jul; 28(3):143-53. PubMed ID: 25711304
[TBL] [Abstract][Full Text] [Related]
3. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 13, Cytokeratin 17, Ki-67 and p53 Expression in Upper Layers of Epithelial Dysplasia Surrounding Tongue Squamous Cell Carcinoma.
Matsuhira A; Noguchi S; Sato K; Tanaka Y; Yamamoto G; Mishima K; Katakura A
Bull Tokyo Dent Coll; 2015; 56(4):223-31. PubMed ID: 26657521
[TBL] [Abstract][Full Text] [Related]
5. [Effect of hypoxia inducible factor-1 alpha on vascular endothelial growth factor expression in human tongue squamous carcinoma cells (Tca8113) under hypoxia].
Zhang XY; Wang X; Sun SZ; Song Y; Yang MX; Qu X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Dec; 42(12):747-9. PubMed ID: 18476562
[TBL] [Abstract][Full Text] [Related]
6. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
7. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
8. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells.
Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R
Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428
[TBL] [Abstract][Full Text] [Related]
9. Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro.
Kang FW; Que L; Wu M; Wang ZL; Sun J
Oncol Rep; 2012 Jul; 28(1):193-9. PubMed ID: 22552321
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane attenuate hypoxia-induced VEGF level in tongue squamous cell carcinoma cell by upregulating the DNA methylation states of the promoter region.
Lu Y; Wang J; Yan J; Yang Y; Sun Y; Huang Y; Hu R; Zhang Y; Jiang H
Biomed Pharmacother; 2015 Apr; 71():139-45. PubMed ID: 25960229
[TBL] [Abstract][Full Text] [Related]
11. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.
Ohyama A; Toyomura J; Tachibana T; Isonishi S; Takahashi H; Ishikawa H
Hum Cell; 2016 Oct; 29(4):188-96. PubMed ID: 27541369
[TBL] [Abstract][Full Text] [Related]
13. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypoxia inducible factor-1alpha (HIF-1alpha) on the growth & adhesion in tongue squamous cell carcinoma cells.
Song Y; Wang W; Qu X; Sun S
Indian J Med Res; 2009 Feb; 129(2):154-63. PubMed ID: 19293442
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-α-TNFR1-NF-κB pathway and a possible involvement of angiopoietin-like 4 in lung metastasis.
Tanaka T; Imamura T; Yoneda M; Irie A; Ogi H; Nagata M; Yoshida R; Fukuma D; Kawahara K; Shinohara M; Nakayama H
Int J Oncol; 2016 Oct; 49(4):1377-84. PubMed ID: 27511626
[TBL] [Abstract][Full Text] [Related]
16. Effect of HIF-1α on biological activation of human tongue squamous cell carcinoma SCC-15 cells in vitro.
Zhou X; Huang D; Xue Z; Xu X; Wang K; Sun Y; Kang F
Int J Oncol; 2015; 46(6):2346-54. PubMed ID: 25816356
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
Fu Z; Chen D; Cheng H; Wang F
Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
[TBL] [Abstract][Full Text] [Related]
18. FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.
Zheng X; Jia B; Lin X; Han J; Qiu X; Chu H; Sun X; Hu W; Pan J; Chen J; Zhao J
Int J Mol Med; 2016 Nov; 38(5):1443-1449. PubMed ID: 27666346
[TBL] [Abstract][Full Text] [Related]
19. Endobronchial ultrasound doppler image features correlate with mRNA expression of HIF1-α and VEGF-C in patients with non-small-cell lung cancer.
Nakajima T; Anayama T; Koike T; Shingyoji M; Castle L; Kimura H; Yoshino I; Yasufuku K
J Thorac Oncol; 2012 Nov; 7(11):1661-7. PubMed ID: 23059773
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
